Mobile

An Open-Label Extension Study to Assess the Long-Term Safety and Efficacy of ISIS 301012 in Patients with Familial Hypercholesterolemia or Severe Hypercholesterolemia

Update Il y a 4 ans
Reference: EUCTR2005-003450-10

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To evaluate the safety and efficacy of extended dosing with ISIS 301012 (mipomersen) in patients with familial hypercholesterolemia or severe hypercholesterolemia on concomitant lipid-lowering therapy

Inclusion criteria

  • Patients with homozygous and heterozygous familial hypercholesterolemia or severe hypercholesterolemia

Links